Legal scholar Kahn notes an increasing trend in conflation of race and genetics in gene-related patent applications, citing “the strategic use of race as a genetic category to obtain patent protection and drug approval” ( 37 ).
← all excerpts
Direct-to-Consumer Genetic Testing's Red Herring: "Genetic Ancestry" and Personalized Medicine.
1
—
—